These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25551538)

  • 1. Inhaled glucocorticoids and COPD exacerbations.
    Brightling CE; Pavord ID; Bafadhel M
    N Engl J Med; 2015 Jan; 372(1):93. PubMed ID: 25551538
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled glucocorticoids and COPD exacerbations.
    Singanayagam A; Johnston SL; Mallia P
    N Engl J Med; 2015 Jan; 372(1):92-3. PubMed ID: 25551537
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled glucocorticoids and COPD exacerbations.
    Cosio M; Baraldo S; Saetta M
    N Engl J Med; 2015 Jan; 372(1):92. PubMed ID: 25551536
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhaled glucocorticoids and COPD exacerbations.
    Magnussen H; Tetzlaff K; Calverley PM
    N Engl J Med; 2015 Jan; 372(1):93-4. PubMed ID: 25551535
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP journal club. For preventing exacerbations of COPD, withdrawal of inhaled glucocorticoids was noninferior to continuation.
    Stanbrook MB
    Ann Intern Med; 2015 Mar; 162(6):JC5. PubMed ID: 25775348
    [No Abstract]   [Full Text] [Related]  

  • 6. Discontinuing inhaled steroids might not be safe in severe COPD cases.
    Laniado-Laborín R
    Evid Based Med; 2015 Apr; 20(2):57. PubMed ID: 25595701
    [No Abstract]   [Full Text] [Related]  

  • 7. Stepping down therapy in COPD.
    Reilly JJ
    N Engl J Med; 2014 Oct; 371(14):1340-1. PubMed ID: 25196116
    [No Abstract]   [Full Text] [Related]  

  • 8. The INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroids.
    Lanes SF; Jara M
    Am J Respir Crit Care Med; 2008 Sep; 178(5):543-4; author reply 544. PubMed ID: 18713851
    [No Abstract]   [Full Text] [Related]  

  • 9. Withdrawal of inhaled glucocorticoids and exacerbations of COPD.
    Magnussen H; Disse B; Rodriguez-Roisin R; Kirsten A; Watz H; Tetzlaff K; Towse L; Finnigan H; Dahl R; Decramer M; Chanez P; Wouters EF; Calverley PM;
    N Engl J Med; 2014 Oct; 371(14):1285-94. PubMed ID: 25196117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.
    Maltais F; Mahler DA; Pepin V; Nadreau E; Crater GD; Morris AN; Emmett AH; Ferro TJ
    Eur Respir J; 2013 Aug; 42(2):539-41. PubMed ID: 23904549
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ; Cates CJ; Poole P
    Cochrane Database Syst Rev; 2013 May; (5):CD007891. PubMed ID: 23728670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence of pharmacotherapy in COPD--key findings from recently-conducted randomized clinical studies].
    Shimizu K; Nishimura M
    Nihon Rinsho; 2011 Oct; 69(10):1815-20. PubMed ID: 22073579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ; Cates CJ; Poole P
    Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
    Wedzicha JA; Calverley PM; Seemungal TA; Hagan G; Ansari Z; Stockley RA;
    Am J Respir Crit Care Med; 2008 Jan; 177(1):19-26. PubMed ID: 17916806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of airway dimensions with once daily tiotropium plus indacaterol versus twice daily Advair(®) in chronic obstructive pulmonary disease.
    Hoshino M; Ohtawa J; Akitsu K
    Pulm Pharmacol Ther; 2015 Feb; 30():128-33. PubMed ID: 25183687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPD.
    Shafazand S
    Ann Intern Med; 2013 Jun; 158(12):JC2. PubMed ID: 23778926
    [No Abstract]   [Full Text] [Related]  

  • 18. Outpatient management of severe COPD.
    Singh S; Loke YK; Furberg CD
    N Engl J Med; 2010 Jul; 363(5):493-4; author reply 494-5. PubMed ID: 20666630
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
    Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
    Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting inhaled bronchodilators for COPD--lack of logic continues.
    Jones D
    N Z Med J; 2005 Sep; 118(1222):U1669. PubMed ID: 16222360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.